NorthSea Therapeutics
PrivateLast Round
Series C
Dec 17, 2021
Total Funding Raised
$149.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NorthSea Therapeutics is a biotechnology company that develops novel therapeutic drugs for metabolic, inflammatory, and liver diseases using its proprietary Structurally Engineered Fatty Acid (SEFA) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NorthSea Therapeutics Comparables
Compare NorthSea Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sagimet Biosciences | 82% | |
| Inventiva S.A. | 80% | |
| Galmed Pharmaceuticals | 79% | |
NorthSea Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 17, 2021 | ||||
| Series B | Jan 8, 2020 | ||||
| Series A | Dec 12, 2017 |
Key People
Founding team and executive leadership
NorthSea Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hercules Capital | Series C |
| Forbion | Series B, Series C, Series A |
| Ysios Capital | Series C |
| Flerie Invest | Series C, Series A, Series B |
| Novo Holdings | Series B, Series C, Series A |
| Novoseeds | Series B, Series C, Series A |
| venBio | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 56% MoM.
- Apr 20, 2026
Monthly visitors grew 503% MoM, reaching 1.6K.
NorthSea Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NorthSea Therapeutics's valuation, stock price, and market status.